Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug. Wise J. BMJ 2025;388:r439.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wise J. Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug. BMJ 2025;388:r439.
PMID: 40032311